Buckingham Capital Management, Inc. Bristol Myers Squibb CO Transaction History

Buckingham Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$57.43 - $63.64 $383,747 - $425,242	-6,682 Closed	0 $0
Q2 2020 Jul 20, 2020	SELL	$54.82 - $64.09 $408,902 - $478,047	-7,459 Reduced 52.75%	6,682 $393,000
Q1 2020 May 06, 2020	SELL	$46.4 - $67.43 $97,440 - $141,603	-2,100 Reduced 12.93%	14,141 $788,000
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $799,219 - $1.04 Million	16,241 New	16,241 $1.04 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Buckingham Capital Management, Inc. with notifications on news.